{"organizations": [], "uuid": "f1f66f9bf20253ea6a5e150e708abdd99cba38d2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "uk.finance.yahoo.com", "main_image": "https://s1.yimg.com/bt/api/res/1.2/M7vS95b2fvSzHFeFStPk0A--/YXBwaWQ9eW5ld3NfbGVnbztxPTc1O3c9NjAw/http://l.yimg.com/os/mit/media/m/social/images/social_default_logo-1481777.png", "site_section": "http://finance.yahoo.com/rss/headline?s=NVS", "section_title": "Yahoo! Finance: NVS News", "url": "https://uk.finance.yahoo.com/news/novartis-buys-remaining-rights-gsk-063424214.html", "country": "US", "title": "Novartis buys remaining rights to GSK treatment for up to $1 bln - Yahoo Finance UK", "performance_score": 0, "site": "yahoo.com", "participants_count": 1, "title_full": "Novartis buys remaining rights to GSK treatment for up to $1 bln - Yahoo Finance UK", "spam_score": 0.0, "site_type": "news", "published": "2015-09-30T03:00:00.000+03:00", "replies_count": 0, "uuid": "f1f66f9bf20253ea6a5e150e708abdd99cba38d2"}, "author": "Reuters - UK Focus", "url": "https://uk.finance.yahoo.com/news/novartis-buys-remaining-rights-gsk-063424214.html", "ord_in_thread": 0, "title": "Novartis buys remaining rights to GSK treatment for up to $1 bln - Yahoo Finance UK", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "RELATED QUOTES Symbol Price Change GSK.L 1,237.50 -13.00 NOVN.VX 87.35 -1.45 NOT.DE 80.41 -0.62 GLAXF 18.55 -0.40", "external_links": [], "published": "2015-09-30T03:00:00.000+03:00", "crawled": "2015-09-30T09:00:45.013+03:00", "highlightTitle": ""}